Australia markets closed

ABBV Jan 2023 115.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
11.36-1.04 (-8.39%)
At close: 11:57AM EST
Full screen
Previous close12.40
Open11.55
Bid10.85
Ask12.00
Strike115.00
Expiry date2023-01-20
Day's range10.75 - 11.55
Contract rangeN/A
Volume66
Open interest2.93k
  • Zacks

    REGENXBIO (RGNX) DMD Gene Therapy Gets Orphan Drug Status

    REGENXBIO (RGNX) is developing a gene therapy candidate, RGX-202, for treating DMD, which is currently in the pre-clinical stage. An IND application is expected by the end of 2021.

  • PR Newswire

    AbbVie to Present at the Evercore ISI Conference

    AbbVie (NYSE: ABBV) will participate in the 4th Annual Evercore ISI Virtual HealthCONx Conference on Thursday, December 2, 2021. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present at 11:10 a.m. CT.

  • PR Newswire

    AbbVie to Present at the Piper Sandler Healthcare Conference

    AbbVie (NYSE: ABBV) will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference on Wednesday, December 1, 2021. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present at 9:30 a.m. CT.